Tanzania - English - Tanzania Medicinces & Medical Devices Authority

indoco remedies limited, india - alumium hydroxide , magnesium hydroxide , simethicone - gel - 100 mg +400 mg + 25 mg

Kenya - English - Pharmacy and Poisons Board

indoco remedies limited indoco remedies limited 166 cst road mumbai india - alumina magnesia and simethicone oral suspension… - gel - dried aluminium hydroxide gel usp 400 mg/ 5 ml… - magnesium antacids compounds

Australia - English - Department of Health (Therapeutic Goods Administration)

omegapharm - acetylcysteine, quantity: 800 mg - solution - excipient ingredients: hydrochloric acid; water for injections; disodium edetate; sodium hydroxide - adjuvant therapy for patients with abnormal, viscid or inspissated mucous secretions in such conditions as: - chronic bronchopulmonary disease (chronic emphysema, emphysema with bronchitis, chronic asthmatic bronchitis, tuberculosis, bronchiectasis and primary amyloidosis of the lung); - acute bronchopulmonary disease (pneumonia, bronchitis, tracheobronchitis); - pulmonary complications of cystic fibrosis; - pulmonary complications associated with surgery; - post-traumatic chest conditions; - atelectasis due to mucus obstruction; - tracheostomy care; - anaesthesia. acetylcysteine may also be used as an adjunct to diagnostic bronchial studies (bronchograms, bronchospirometry and bronchial wedge catheterisation).

Australia - English - Department of Health (Therapeutic Goods Administration)

omegapharm - acetylcysteine, quantity: 2000 mg - solution - excipient ingredients: disodium edetate; sodium hydroxide; water for injections; hydrochloric acid - adjuvant therapy for patients with abnormal, viscid or inspissated mucous secretions in such conditions as: - chronic bronchopulmonary disease (chronic emphysema, emphysema with bronchitis, chronic asthmatic bronchitis, tuberculosis, bronchiectasis and primary amyloidosis of the lung); - acute bronchopulmonary disease (pneumonia, bronchitis, tracheobronchitis); - pulmonary complications of cystic fibrosis; - pulmonary complications associated with surgery; - post-traumatic chest conditions; - atelectasis due to mucus obstruction; - tracheostomy care; - anaesthesia. acetylcysteine may also be used as an adjunct to diagnostic bronchial studies (bronchograms, bronchospirometry and bronchial wedge catheterisation).

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

ayur centre sdn. bhd. - aegle marmelos; desmodium gangeticum; gmelina arborea; oroxylum indicum; pseudarthria viscida; tribulus terristris (extract) standardised; solanum virginianum radix; radix stereospermum colais; radix solanum anguivi; radix premma corymbosa -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

bty worldwide sdn.bhd. - ramulus et folium visci articulatum; radix angelicae sinensis extract; fructus litsea cubeba; folium pterospermum heterophyllum; caulis spatholobus suberectus; caulis piper kadsura; radix achyranthis bidentatae -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

bty worldwide sdn.bhd. - radix dipsacus asperoides; radix angelica pubescentis; herba visci coloratum; herba erodii seu geranii; fructus chaenomeles speciosa; flos carthamus tinctorius; caulis piperis futokadsurae -

United States - English - NLM (National Library of Medicine)

navisci pte. ltd. - vigabatrin (unii: gr120krt6k) (vigabatrin - unii:gr120krt6k) - vigabatrin for oral solution is indicated as adjunctive therapy for adults and pediatric patients 2 years of age and older with refractory complex partial seizures who have inadequately responded to several alternative treatments and for whom the potential benefits outweigh the risk of vision loss [see warnings and precautions (5.1)]. vigabatrin for oral solution is not indicated as a first line agent for complex partial seizures. vigabatrin for oral solution is indicated as monotherapy for pediatric patients with infantile spasms 1 month to 2 years of age for whom the potential benefits outweigh the potential risk of vision loss [ see warnings and precautions ( 5.1 )]. none. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to aeds, including vigabatrin, during pregnancy. encourage women who are taking vigabatrin during pregnancy to enroll in the north american antiepileptic drug (naaed) pregnancy registry. this can be done by calling the to

Israel - English - Ministry of Health

teva pharmaceutical industries ltd, israel - bromhexine hydrochloride - tablets - bromhexine hydrochloride 8 mg - bromhexine - bromhexine - mucolitic expectorant in conditions associated with the retention of viscid mucoid secretion in the respiratory tract e.g. :bronchitis asthma and sinusitis.

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

ep plus group sdn. bhd. - n-acetylcysteine -